Australia-based global forex broker, IC Markets is expanding its retail business by adding 950 new stock CFDs and 3 crypto CFDs into their platform, including vaccine manufacturer, BioNTech.
Founded in 2007, IC Markets broker, who has successfully held licenses in Australia, Cyprus, Seychelles, and the Bahamas, offers a wide range of derivative trading products including Forex, indices, commodities, and the latest 950 stocks and 3 cryptocurrencies.
Commenting on the new instrument addition, IC Markets CEO Andrew Budzinski said this was in response to client requests. IC Markets doesn't stop there as they also committed to continuously adding new products according to the clients' wishes.
Budzinski added, IC Markets' main focus is to provide customers with the best trading experience, and one of the ways is by offering a variety of trading instruments so that clients can diversify their portfolios. For these efforts, the Sydney-based broker reported a record trading volume exceeding the $1 trillion mark in March.
IC Markets Introduces BioNTech and Polkadot
The trading instruments added by this Forex and CFDs brokerage are 950 company shares and 3 cryptocurrencies. Stock products include stock CFDs from German global Covid vaccine manufacturer BioNTech; consumer technology company, Eventbrite; then the eCommerce platform provider, Shopify.
For the cryptocurrency category, IC Markets added the three most in-demand coins in recent times: Polkadot, Stellar, and Chainlink. The three cryptocurrencies will complete the list of CFDs for Bitcoin, Ethereum, Litecoin, and several others that IC Markets has introduced since 2017.